Two of the most promising options today are Semaglutide and Tirzepatide
Although GLP-1 RAs have demonstrated efficacy even without structured behavioral support, their broader therapeutic potentialparticularly regarding long-term behavior change, psychological stabilization, and sustained weight lossmay be most effectively realized when embedded within a biopsychosocial framework
If you have any concerns, speak to a healthcare professional. Medications include: GLP-1 therapy (glucagon-like peptide-1 receptor agonists) Liraglutide as Saxenda and Semaglutide as Wegovy
Identification of oxadiazoles as new drug leads for the control of schistosomiasis
Other experts said they are concerned about the unintended consequences of the drugs, such possible effects on growth and development
Therefore, the quest for effective obesity treatments, especially those that target pancreatic lipase for the reduction of fat absorption, reveals both challenges and opportunities